A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

Clinical trial NCT07197554 · RECRUITING

Trial details

NCT number: NCT07197554
Sponsor: SEED Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Ewing Sarcoma Hepatocellular Carcinoma (HCC)Biliary Tract Cancer (BTC)

Start date: 2025-12-01
Primary completion: 2029-12-31
Enrollment: 171

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.